Clinical trial
Romidepsin in Treating Patients With Locally Advanced or Metastatic…
NCT00084461 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00084461 |
|---|---|
| Title | Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors |
| Official title | Phase II Study of Depsipeptide in Metastatic Neuroendocrine Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastrinoma, Glucagonoma, Insulinoma, Metastatic Gastrointestinal Carcinoid Tumor, Pancreatic Polypeptide Tumor, Pulmonary Carcinoid Tumor, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell Carcinoma, Regional Gastrointestinal Carcinoid Tumor, Somatostatinoma |
| Intervention type | Drug, Other |
| Interventions | romidepsin, laboratory biomarker analysis |
| Enrollment | 25 |
| Start date | Mar 1, 2004 |
| Primary completion | Oct 1, 2004 |
| First posted | Jun 11, 2004 |
| Last update posted | Jun 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: